Table 2 Non-invasive ventilation treatment among the study population, including non-invasive pressure support ventilation (PSV) and high-flow non-invasive continuous positive airway pressure (CPAP)
From: Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases
Characteristic | Study population 60 (100) |
|---|---|
n. (%) | 60 (100) |
CPAP Treatment | 40 (67) |
CPAP Generator | |
High-flow Venturi | 23 (38) |
Ventilator | 15 (25) |
Boussignac Mask | 2 (3.3) |
CPAP interface | |
Helmet | 28 (70) |
Nasal Mask | 6 (15) |
Face mask | 6 (15) |
CPAP Initial PEEP, median (IQR) | 8 (8–10) |
CPAP Initial FiO2, median (IQR) | 50 (50–100) |
PSV Treatment | 20 (33) |
PSV interface | |
Face mask | 15 (75) |
Nasal Mask | 3 (15) |
Helmet | 2 (10) |
PSV Initial PEEP, median (IQR) | 5 (5–8) |
PSV Initial PS, median (IQR) | 15 (10–20) |
PSV Initial FiO2, median (IQR) | 50 (29–60) |